Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Feb 13 2025 | New Multicenter Study Highlights Utility of Daxor’s Blood Volume Analysis in Heart Failure Care Industry News In The News Industry Read More Feb 11 2025 | Cardio-Oncology and Heart Failure Highlighted in the February 2025 issue of Journal of Cardiac Failure (JCF) HFSA News Journal of Cardiac Failure Press Release Read More Feb 11 2025 | BEYONTTRA™ (acoramidis), the First Near Complete TTR Stabilizer (≥90%), Approved by the European Commission to Treat ATTR-CM Industry News In The News Industry Read More Feb 10 2025 | Where Science Meets Innovation: Why You Should Publish with JCF-Intersections HFSA News Journal of Cardiac Failure Read More Feb 9 2025 | Why Heart Failure Should Matter to You and Your Family: Promoting Heart Failure Awareness Week 2025 Patient News Heart Failure Awareness 365 Patient Resource Read More Pagination First page « First Previous page ‹ Previous … Page 19 Page 20 Page 21 Page 22 Current page 23 Page 24 Page 25 Page 26 Page 27 … Next page Next › Last page Last »
Feb 13 2025 | New Multicenter Study Highlights Utility of Daxor’s Blood Volume Analysis in Heart Failure Care Industry News In The News Industry Read More
Feb 11 2025 | Cardio-Oncology and Heart Failure Highlighted in the February 2025 issue of Journal of Cardiac Failure (JCF) HFSA News Journal of Cardiac Failure Press Release Read More
Feb 11 2025 | BEYONTTRA™ (acoramidis), the First Near Complete TTR Stabilizer (≥90%), Approved by the European Commission to Treat ATTR-CM Industry News In The News Industry Read More
Feb 10 2025 | Where Science Meets Innovation: Why You Should Publish with JCF-Intersections HFSA News Journal of Cardiac Failure Read More
Feb 9 2025 | Why Heart Failure Should Matter to You and Your Family: Promoting Heart Failure Awareness Week 2025 Patient News Heart Failure Awareness 365 Patient Resource Read More
